Pathstone Holdings »

Cytokinetics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8M 35k 52.80
2024-06-30 $1.6M 30k 54.18
2024-03-31 $1.3M 19k 70.11
2023-12-31 $916k 11k 83.49

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Coca-Cola Company (KO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Pathstone Holdings

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
Bank of America Corporation
Armistice Capital
T. Rowe Price Associates
Geode Capital Management
Rtw Investments
Polar Capital Holdings
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA

View all funds holding Cytokinetics